Patients with a hard-to-treat type of cancer are being given new hope in a new clinical trial.
Researchers at the University of Southampton and the University of Leicester are trialing a drug that could boost the body’s immune system to fight off mesothelioma, which can be caused by asbestos.
Copy and paste this URL into your WordPress site to embed
